phase 2 – CFN Media

Analyst and Research Coverage Bullish on Cardiol Therapeutics

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) has in some ways burst…

Robin Lefferts
May 1, 2024

The Impact of Positive Phase 2 Trial Results on a Smaller Company

A few weeks back, we covered the effect an Orphan Drug Designation…

Robin Lefferts
March 12, 2024

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Stella Emory

Wilson Augustine

Mining Stocks

Advanced Gold Exploration Inc. Files NI 43-101 Technical Report for the Silver Belle Project in Nevada

Vancouver, British Columbia–(Newsfile Corp. – August 12, 2026)…

Ryan Allway
August 13, 2026

Mining Stocks

First Phosphate to Ring Nasdaq Opening Bell to Mark Company Listing on the Nasdaq Global Market

Saguenay, Quebec–(Newsfile Corp. – August 13, 2026) – First Phosphate…

Ryan Allway
August 13, 2026

AXIL Brands: A Fundamental Small Cap Growth Story

Small- and micro-cap investment stories are usually built around potential more than…

Robin Lefferts
August 11, 2026

How CardiolRx™ Could Fit Into the Recurrent Pericarditis Treatment Regimen

Recurrent pericarditis (RP) is a debilitating disease in need of better forms…

Robin Lefferts
August 11, 2026